US12648L6011 - Common Stock
CTI BIOPHARMA CORP
NASDAQ:CTIC (6/23/2023, 7:00:00 PM)
After market: 9.09 0 (0%)9.09
0 (0%)
CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. The company is headquartered in Seattle, Washington and currently employs 128 full-time employees. The firm is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). The company is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. Its earlier stage product candidate, tosedostat, is an oral, once-daily aminopeptidase inhibitor that has demonstrated responses in patients with acute myeloid leukemia (AML). The company also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. The company is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer.
CTI BIOPHARMA CORP
3101 Western Ave Ste 800
Seattle WASHINGTON 98121
P: 12062827100.0
CEO: Adam R. Craig
Employees: 128
Website: https://www.ctibiopharma.com/
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer.
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (SobiĀ®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the completion of the...
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (SobiĀ®) (STO: SOBI) announced today that it has, through its indirect wholly owned subsidiary Cleopatra...
/PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel...
Here you can normally see the latest stock twits on CTIC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: